P50CA101942/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	1
2006	1
2007	1
2009	1
2010	3
2011	2
2012	4
2013	7
2014	5
2015	9
2016	1
2024	0

1

Combination cancer immunotherapy and new immunomodulatory targets.

Mahoney KM, Rennert PD, Freeman GJ. Mahoney KM, et al. Nat Rev Drug Discov. 2015 Aug;14(8):561-84. doi: 10.1038/nrd4591. Nat Rev Drug Discov. 2015. PMID: 26228759 Review.

2

Dual inhibition of PI3-kinase and mTOR in renal cell carcinoma.

Cho DC, Mier JW. Cho DC, et al. Curr Cancer Drug Targets. 2013 Feb;13(2):126-42. doi: 10.2174/1568009611313020003. Curr Cancer Drug Targets. 2013. PMID: 23259857 Review.

3

Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?

Bhatt RS, Atkins MB. Bhatt RS, et al. Clin Cancer Res. 2014 Jun 1;20(11):2838-45. doi: 10.1158/1078-0432.CCR-13-2788. Epub 2014 Apr 8. Clin Cancer Res. 2014. PMID: 24714770 Free PMC article. Review.

4

Treatment selection for patients with metastatic renal cell carcinoma.

Atkins MB, Choueiri TK, Cho D, Regan M, Signoretti S. Atkins MB, et al. Cancer. 2009 May 15;115(10 Suppl):2327-33. doi: 10.1002/cncr.24231. Cancer. 2009. PMID: 19402069 Free PMC article. Review.

5

Novel targeting of phosphatidylinositol 3-kinase and mammalian target of rapamycin in renal cell carcinoma.

Cho D. Cho D. Cancer J. 2013 Jul-Aug;19(4):311-5. doi: 10.1097/PPO.0b013e31829d5cea. Cancer J. 2013. PMID: 23867512 Free PMC article. Review.

6

Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.

Akhavanfard S, Vargas SO, Han M, Nitta M, Chang CB, Le LP, Fazlollahi L, Nguyen Q, Ma Y, Cosper A, Dias-Santagata D, Han JY, Bergethon K, Borger DR, Ellisen LW, Pomeroy SL, Haber DA, Iafrate AJ, Rivera MN. Akhavanfard S, et al. Genes Chromosomes Cancer. 2014 Jan;53(1):67-77. doi: 10.1002/gcc.22118. Epub 2013 Nov 5. Genes Chromosomes Cancer. 2014. PMID: 24249259

7

Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.

Concha-Benavente F, Srivastava RM, Trivedi S, Lei Y, Chandran U, Seethala RR, Freeman GJ, Ferris RL. Concha-Benavente F, et al. Cancer Res. 2016 Mar 1;76(5):1031-43. doi: 10.1158/0008-5472.CAN-15-2001. Epub 2015 Dec 16. Cancer Res. 2016. PMID: 26676749 Free PMC article.

8

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma.

Michaelson MD, McKay RR, Werner L, Atkins MB, Van Allen EM, Olivier KM, Song J, Signoretti S, McDermott DF, Choueiri TK. Michaelson MD, et al. Cancer. 2015 Oct 1;121(19):3435-43. doi: 10.1002/cncr.29503. Epub 2015 Jun 8. Cancer. 2015. PMID: 26058385 Free article. Clinical Trial.

9

Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer.

Giraldo NA, Becht E, Pagès F, Skliris G, Verkarre V, Vano Y, Mejean A, Saint-Aubert N, Lacroix L, Natario I, Lupo A, Alifano M, Damotte D, Cazes A, Triebel F, Freeman GJ, Dieu-Nosjean MC, Oudard S, Fridman WH, Sautès-Fridman C. Giraldo NA, et al. Clin Cancer Res. 2015 Jul 1;21(13):3031-40. doi: 10.1158/1078-0432.CCR-14-2926. Epub 2015 Feb 16. Clin Cancer Res. 2015. PMID: 25688160

10

Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies.

Choueiri TK, Je Y, Cho E. Choueiri TK, et al. Int J Cancer. 2014 Jan 15;134(2):384-96. doi: 10.1002/ijc.28093. Epub 2013 Sep 23. Int J Cancer. 2014. PMID: 23400756 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year